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Abstract 
 
Background: Little research has been undertaken on children and adolescents with psychiatric co-morbidity and this group 
is seldom subject to evidence-based treatment. Equally, there has been little research on creating an evidence base for 
Narrative Therapy, which means that narrative family therapy (NFT) is seldom available to children and adolescents with a 
psychiatric disorder.  
Objective: A single group clinical design was used to examine the efficacy of NFT for children and adolescents with 
different diagnoses. 
Method: Families receiving NFT from the Family Therapy Team (FTT) at the Child and Adolescent Mental Health 
Services (CAMHS) of the Capital Region of Denmark filled out psychometric measurements before and after treatment. 
Patients evaluated the burden of symptoms using Beck’s Youth Inventory (BYI), and parents evaluated their personal 
agency in relationship to their child’s psychiatric disorder using Parent Activation Measurement (PAM).  
Results: We analyzed data from 48 patients and found a significant increase in median BYI measures of Self-Concept (40.5 
to 46.0, p = 0.002) with an effect size of 0.60, decreases in BYI Depression Index (58.0 to 54.0, p = 0.030) with an effect 
size of –0.41, decreases in BYI Disruptive Behaviour Index (48.0 to 43.0, p = 0.030) with an effect size of –0.38, and a 
significant increase in PAM from 56.4 to 68.5, p = 0.001 with an effect size of 0.61. 
Conclusion: Results from this study suggest that NFT has a direct positive effect on patients’ own evaluation of the burden 
of symptoms, and parents’ perceived personal agency regarding their child’s distress.  
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Introduction 
The Family Therapy Team (FTT) is part of Child and 
Adolescent Mental Health Services (CAMHS) in the 
Capital Region of Denmark. It was established to 
help families continuing to suffer even after having 
received regular treatment from CAMHS, the school 
system and social services. Families are thus referred 
from other parts of CAMHS when standard 
treatments are not considered sufficient. The 
referred child usually suffers from one or more 
psychiatric diseases, often with unusual or aggravated 
symptoms. The majority of presenting families have 
more than one member who suffers from a 
psychiatric or somatic disease. 
The narrative family therapy (NFT) offered is 
family therapy in a narrative psychiatric context, 
based on two hypotheses. Whenever a child is 
suffering from a psychiatric disease, all members of 
the family are affected, and thus the whole family 
needs help. When parents’ sense of personal agency 
is negatively affected by the child’s suffering, helping 
the parents achieve increased personal agency, 
especially mastery of their child’s psychiatric disease, 
is a necessary component of treatment.  
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Narrative therapy principles were first developed 
by Michael White and David Epston (1-8). Narrative 
therapy does not directly aim to reduce symptoms. 
Instead, it focuses on changing a person’s 
relationship with the problem and changing their 
narratives about themselves and their problem. The 
fundamental aim of narrative therapy is for a person 
to experience a greater general sense of agency both 
towards themselves and towards the problem. 
Narrative therapists ground their work in social 
constructivist and post-structural theory and 
consider how the power of stories shapes peoples’ 
identities and lives.  
NFT builds on narrative therapy. The NFT 
practiced at the CAMHS clinic has a specific 
engagement with Madsen (9). CAMHS therapists 
work collaboratively alongside families with an overt 
expectation that families have the ability to deal with 
the psychiatric problems in their lives and can 
experience themselves as having personal agency and 
power. Our manual for NFT consists of three 
elements: The therapeutic sessions, network 
meetings (with the school and municipality), and 
written documents (most important therapeutic 
letters after each session and the treatment plan). The 
parents decide who participates in the different 
sessions (the parents alone, the parents, and the 
appointed patient, the whole family, the extended 
family, the siblings, the patient, friends of the 
patients). The treatment consists of three phases, a 
clarification, a working, and a termination phase. 
Every fifth session in the working phase is a ”taking 
stock”-session. Externalizing problems, resources, 
ideals, and hopes are the grammar of the therapeutic 
language, and the manual demands that the clinical 
work is based on the four principles: Respect, trust, 
curiosity, and hope. The therapists ask questions 
aiming to help the family members build knowledge 
and wisdom, based on their own hopes and dreams. 
The statements, the therapists consider most helpful 
for the family are written on a big paperboard during 
the session. A detailed description of NFT can be 
read in our manual1. The considerations of 
developing the Danish NFT manual have been 
described in detail elsewhere (10).  
Narrative therapy is seldom the subject of 
quantitative research (11), perhaps because narrative 
therapy avoids using diagnostic classifications in 
order to privilege “the voice of those who consult 
with us … working with their truth and their version 
of reality” (12). For some, this makes it unsuitable for 
quantitative research methods. Some narrative 
therapists are even actively opposed to quantitative 
methods (13). This relative lack of quantitative 
                                                     
1 Manual for Samarbejdende familieterapi med psykiatrisk 
multistressede familier [Manual for Collaborative Family Therapy 
with Psychiatric Multi-Stressed Families], October 2013 
evidence for NFT is problematic for practitioners of 
narrative therapy in public healthcare settings with 
demands for evidence-based practice. Without 
robust clinical evidence, NFT risks are marginalized 
(9,12,14) and will not become a potential treatment 
available for patients seeking help at CAMHS.  
Several studies have sought to show the 
effectiveness of narrative therapy by conducting it 
alongside established improvement measurements, 
typically through quasi-experimental (non-
randomized) studies. An NFT intervention aiming to 
reduce parent/child conflict with six families found 
five of six families showed improvement in 
parent/child conflict as rated by parents using a 
multiple baseline analysis (15). A study of 10 young 
people with autism, offering five one-hour sessions 
of individual narrative therapy over 10 weeks found 
significant improvement according to both 
psychological distress measured by the Kessler-10 
Scale and according to the emotional symptoms of 
the Strength and Difficulties Questionnaire (16). A 
school intervention aiming to enhance pupils’ self-
esteem used a mixed method approach with a single 
group repeated measures design. Using the Beck’s 
Youth Inventory (BYI) scale, it found significant 
improvement of self-concept between pre- and post-
intervention (17). Vroman and Schweitzer (18) 
studied an adult population with major depressive 
disorder receiving manualized narrative therapy. 
They compared each person’s scores against 
normative results in the evaluation of clinical 
significance and utilized benchmarking and clinical 
significance as alternatives to a RCT design. The 
manual was principle based, and they developed a 
treatment integrity measure for evaluating adherence 
and competence. They found 74% of the clients 
achieving a reliable improvement, 61% achieved a 
population functional level, and a clinically 
significant improvement comparable to benchmark 
research outcomes. The 3-months follow-up showed 
maintenance of symptoms, but not interpersonal 
relatedness improvement. 
Bargenquast and Schweitzer (19) examined the 
effectiveness of an innovative, manualized 
psychotherapy drawing on three principles, one of 
them narrative therapy. They found adult patients 
significantly improved on the general outcome of 
subjective recovery and treatment-specific outcomes 
of self-reflectivity. This was quantitatively assessed 
using a single-sample, pre- and post-therapy design 
and qualitatively assessed using a case-study 
methodology. A life story intervention for individuals 
with intellectual disabilities and psychiatric problems 
was described, and quantitative analyses showed a 
[unpublished]. For a copy of the manual, please, contact the 
corresponding author. 
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decrease in total psychiatric complaints from pre- to 
post-treatment, which was still significant at follow-
up (20). Bohlmeijer undertook a quasi-experimental 
(non-randomized) study to measure effects on an 
adult population with depression receiving a 
narrative therapy intervention called “The story of 
your life” that showed significantly fewer depressive 
symptoms and higher mastery compared to a waiting 
list group (21). Similarly, Seo deployed a quasi-
experimental design to explore the effectiveness of a 
“narrative therapy with an emotional approach” 
program for people with depression (22). This 
showed significant positive effects on depressive 
symptoms and cognitive-emotional outcomes 
through measurements using a self-awareness scale, 
the Nowotny Hope Scale, the Positive Affect and 
Negative Affect Scale, and the Center for 
Epidemiological Studies-Depression Scale. 
We developed NFT and called it Collaborative 
Family Therapy in our manual to honor the 
hypothesis we learned from William Madsen, here 
formulated by us: When problems within a family is 
really complex, helping is a messy business. But a 
collaborative stance based on narrative theory shows 
us a way through the messy business and make it 
possible to offer help that helps. 
 
Aims of the study 
The study aimed to do a quantifiable study of our 
original hypothesis, by evaluating whether NFT has 
any measurable and quantifiable effect on the 
patients’ experience of specific psychiatric 
symptoms, and parents’ sense of personal agency. 
We hypothesized that we would observe statistically 
significant changes in BYI and Parent Activation 
Measurement (PAM) scores from baseline to follow-
up. Thus, the study analyzed how measurements 
change pre- and post-treatment with NFT.  
 
Method  
Recruitment  
Participants included in this study were families 
receiving NFT in the FTT at the Capital Region of 
Denmark CAMHS, which follows the accreditation 
standards and regulations of Child and Adolescent 
Psychiatry in the Capital Region of Denmark. The 
families were referred because they had continued 
suffering, despite having received treatments as usual 
from CAMHS, the school system and social services. 
All families were referred from other parts of the 
same CAMHS. None had received any treatment 
addressing the effects of the psychiatric problems on 
the family as a whole. The aim was to provide this 
missing treatment that neither the traditional therapy 
specific towards the psychiatric disease, nor family 
therapy specific towards family dynamics address. 
Parents and children filled out psychometric 
measurements before and after treatment to evaluate 
the burden of symptoms. The number of treatment 
sessions differed from family to family, depending on 
their needs and wishes. In NFT, families decide the 
termination date in collaboration with the clinicians 
and a positive NFT outcome is considered to be 
when the family feels confident to go on without help 
from the FTT.  
 
Participants and measurements 
Families were given full anonymity and the review of 
data processing was undertaken according to the 
standard safety regulations of the Capital Region 
concerning the processing of personal information 
under the Privacy Act. The families were informed of 
the study at the initial telephone conversation. They 
were given written and oral information of the 
purpose of the project at the initial meeting where 
they consented to participating in the project when 
patients and parents also completed the pre-outcome 
psychometric measurements. Post-outcome 
psychometric measurements were undertaken just 
before the final session at the clinic. Children and 
adolescents aged 8 to 17 filled in the BYI, which 
measures the perceived burden of common 
symptoms such as anxiety, depression, anger, 
disruptive behavior, and self-concept. We chose BYI 
for the children because they were addressing 
symptoms across different diagnoses and the 
Inventory includes both negatively and positively 
formulated descriptions. Parents evaluated their 
personal agency in relationship to their child’s 
psychiatric disorder through the PAM, which 
measures the parent’s sense of personal activation 
towards their child’s psychiatric illness (23). We 
chose PAM as the measurement most closely 
resembling a positive description of self-agency, 
since we hoped for a positive effect on the parents’ 
sense of self-agency towards their child’s illness.  
 
The Beck Youth Inventory 
BYI measures the perceived burden of common 
symptoms of anxiety, depression, anger, disruptive 
behavior, and self-concept (24). BYI is characterized 
by including acceptable psychometric properties and 
is based on published Danish norms (25, 26). It is a 
self-report measure that contains questions which are 
both positively and negatively framed and focus on 
both problem and non-problem related areas of the 
child’s life. The BYI consists of five inventories of 20 
statements each regarding the thoughts, emotions, 
and behaviors within the five domains. The child is 
asked to rate how frequently the statement has been 
true within the past two weeks. The choice of BYI 
was based on a review of existing psychometric 
measures for use in Danish CAMHS in 2013. 
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The Parent Activation Measurement 
PAM measures the parents’ sense of personal 
activation towards their child’s psychiatric illness 
(23). It builds on the 13-item PAM, which originally 
focused on measuring patient activation towards 
physical conditions as a broad construct. Green (27) 
developed the PAM-Mental Health (PAM-MH) by 
adapting the 13-item PAM to specifically assess 
mental health-related activation. Subsequently a 
parent activation score was developed by Pennarola 
(23). We found the PAM to be the most useful 
measurement available, and we have previously 
described the process of choosing and implementing 
these psychometric measurements (28). We 
translated the PAM assessment (23) into Danish and 
back-translated it by an independent translator to 
verify accuracy.  
There is still limited research about parental 
activation on behalf of their children even though the 
PAM measure is licensed for commercial and 
research use by its developers. Since the 
psychometric properties for the PAM measurements 
have not been researched, there are no norms for 
PAM (Danish or otherwise), and the measurement is 
not as rigorous as those we chose for the children 
(29). The parents’ scores were converted to an 
activation score from 0 to 100, where any scores 
below 55.2 show lack of personal confidence and 
knowledge to take action, or lack of belief that they 
can take action.  
 
Statistical analysis 
We used a single sample, pre- and post-therapy 
design and descriptive statistics for baseline values, 
mean ± standard deviation (SD) for parameters that 
were normally distributed, and median (interquartile 
range [IQR]) for those that were not. BYI raw scores 
for each domain were converted into T-scores based 
on age and sex. A T-score of 55 or less = average 
score, 55 to 59 = mildly elevated, 60 to 69 = 
moderately elevated and ≥70 = extremely elevated 
depression. We compared distribution of patients 
across these categories before and after treatment. 
To evaluate differences from baseline to follow-up in 
PAM and BYI outcomes, as well as differences in 
distribution across categories, we used Wilcoxon 
Signed Rank Test for Related Samples, and the 
Cohen’s d-test. 
 
Results  
Descriptive data 
One hundred and five patients were enrolled during 
the study period, but complete data are only available 
for 48 patients. We have found no difference in age, 
gender, duration of treatment, number of sessions 
and psychiatric diagnosis between those who filled 
out questionnaires, and those who did not. We can 
only suppose that data incompleteness is because 
data were obtained during the initial NFT manual 
implementation and training period, which took 
longer than anticipated (28). Twenty-eight (58.3%) 
patients were girls and 20 (41.7%) were boys (p = 
0.005). Median age at treatment initiation was 13.2 
(IQR 11.2 to 14.9) years. Mean ± SD duration of 
treatment was 368.0 ± 224.4 days. Median number of 
sessions was 16 (IQR 11 to 29). We excluded three 
participants: one adolescent did not want family 
therapy and two adolescents stopped the therapy 
because they turned 18 and were referred to other 
treatment in adult psychiatry. We excluded these 
participants because we would have continued the 
treatment, if they had not turned 18 (Table 1).  
 
 
 
TABLE 1. Demographics 
Age, years (median (IQR)) 13.2 (11.2 to 14.9) 
Sex  
 Female, n (%) 28 (58.3%) 
 Male, n (%) 20 (41.7%) 
Treatment duration, days (mean ± SD) 368.0 ± 224.4 
Number of sessions (median (IQR)) 15.5 (11.0-28.5) 
  
Primary diagnostic categories  
Psychotic disorders, ICD-10 category DF2XX 1 (2.1%) 
Affective disorders, DF3XX 6 (12.5%) 
Anxiety disorders, DF4XX 9 (18.8%) 
Eating disorders, DF5XX 10 (20.8%) 
Developmental disorders, DF8XX 10 (20.8%) 
Behavioural disorders, DF9XX 12 (25.0%) 
Total 48 (100.0%) 
Note. ICD-10, International Classification of Diseases, 10th ed.;  
IQR, InterQuartile Range; SD, standard deviation 
 
 
 
There were no significant gender differences across 
diagnostic categories. Twenty-two patients (45.8%) 
received psychotropic medication, whereas seven 
(14.6%) patients were prescribed two or more 
medications in the intervention period. Forty-one of 
the patients had secondary diagnoses: seven had one 
secondary diagnosis, nine had two secondary 
diagnoses, eight had three secondary diagnoses, 
seven had four secondary diagnoses (for one patient 
two of these were somatic diagnoses), three had five 
secondary diagnoses, four had six secondary 
diagnoses (for one patient two of these were somatic 
diagnoses, for two patients one of these was a 
somatic diagnoses), two had eight secondary 
diagnoses (for these two patients one of these was a 
somatic diagnosis) and one patient had nine 
secondary diagnoses (for this patient two of these 
were somatic diagnoses). 
 
Pre- and post-measurements 
All measurements showed improvement for both 
patients and parents, with the biggest statistical 
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significance and highest effect sizes for the patients’ 
self-concept and the PAM. When the data were 
analyzed specifically for children who had a 
pathological score, the p-values increased (see Table 
2). 
 
 
 
 
TABLE 2. Change in symptom scores, median (IQR) 
  
Baseline 
 
After treatment 
 
Cohen’s d 
 
p 
All patients 
Parent Activation Measurement  56.4 (49.9 to 65.4) 68.5 (59.1 to 75.3) 0.61 0.001 
Beck Self-Concept Index  40.5 (32.0 to 52.5) 46.0 (37.5 to 59.5) 0.60 0.002 
Beck Anxiety Index  56.0 (47.5 to 66.0) 53.0 (45.0 to 61.0) –0.24 0.214 
Beck Depression Index  58.0 (48.5 to 69.5) 54.0 (43.5 to 60.0) –0.41 0.030 
Beck Anger Index  51.0 (40.0 to 62.0) 50.0 (37.0 to 57.0) –0.20 0.299 
Beck Disruptive Behavior Index  48.0 (39.0-56.0) 43.0 (34.0 to 51.0) –0.38 0.030 
Total Negative symptom score  211.0 (181.0 to 243.0) 195.0 (171.0 to 223.0) –0.20 0.108 
          
Patients with elevated baseline scores 
Beck Self-Concept Index  32.0 (27.0 to 39.0), n=21 44.0 (35.5 to 54.5), n=18 1.00 0.001 
Beck Anxiety Index  67.5 (64.5 to 73.8), n=16 59.0 (53.0 to 68.0), n=15 –0.24 0.011 
Beck Depression Index  70.0 (65.5 to 73.5), n=17 56.5 (49.0 to 63.25), n=14 –0.41 0.001 
Beck Anger Index  69.0 (63.0 to 73.0), n=11 58.0 (54.5 to 65.25), n=10 –0.20 0.025 
Beck Disruptive Behavior Index  61.5 (60.8 to 65.3), n=6 60.0 (51.5 to 63.5), n=5 –0.24 0.416 
Note. IQR: InterQuartile Range 
 
 
 
 
We have three main findings: 
1. We found that psychiatric symptoms (anxiety, 
depression, anger, self-concept, and disruptive 
behavior) measured in pre-therapy BYI test 
showed improvement after the NFT 
intervention when tested in post-therapy BYI 
tests. The changes were statistically significant 
for self-concept (p = 0.002), and significant for 
depression (p = 0.030) and disruptive behavior 
(p = 0.030). The effect sizes were medium to 
large for self-concept, small to medium for the 
depression and disruptive behavior, and small 
for anxiety and anger. 
 
2. Children who had pre-therapy scores 
demonstrating that they were suffering within 
the psychopathological range for one or several 
of the psychiatric symptoms changed more than 
the group as a whole. The change was highly 
statistically significant for self-concept (p = 
0.001) and depression (p = 0.001), and 
statistically significant for anxiety (p = 0.011) 
and anger (p = 0.025). The effect sizes were 
basically the same as for the whole group. This 
suggests that NFT does have a specific and 
positive effect on psychiatric symptoms when 
they are perceived as pathologically 
burdensome.  
 
3. The parents’ activation measurement changed 
from pre-therapy to post-therapy. The effect 
size was medium to large, indicating that NFT 
has a positive effect for the parents perceived 
sense of agency in relationship to the child’s 
psychiatric problems. 
 
Discussion 
The purpose of the present study was to examine if 
it was possible to quantitatively evaluate the effects 
of NFT on the mental health status of patients 
admitted to our clinic, using standardized tools. 
To the best of our knowledge this is the first study 
based on a specific manual for NFT for children and 
adolescents with psychiatric disorders. The manual 
was developed for a very diverse group of patients, 
with different diagnoses and a broad age group. In 
this respect, our manual differs from many others. It 
does not address specific problems or diagnoses but 
aims to give families a language for, and ways of 
placing themselves in, a more powerful position with 
regard to their different problems.  
Our data show a statistically significant increase in 
BYI self-concept index (p = 0.002), with effect size 
in the medium to large range, as well as decreases in 
both depression index and disruptive behavior index 
(both: p = 0.030), with small to medium effect sizes.  
In children with baseline BDI-indices in the 
pathological range, reflecting clinically significant 
symptoms (for instance, elevated BDI depression 
index in patient with symptoms of severe 
depression), NFT significantly improved these 
indices. This effect was seen for all indices except 
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disruptive behavior index. Although the effect sizes 
were small in this restricted sample; our data support 
the hypothesis that NFT can alleviate clinically 
relevant symptoms regardless of underlying 
diagnosis.  
Finally, we found a statistically significant increase 
in PAM. This is also in line with the principles of 
narrative therapy, in which treatment of the patient 
involves not only the patient but the entire family. A 
review of the parental factors influencing on mental 
problems in children (30) suggests that although 
parental factors only account for a small amount of 
variance in child outcomes, “there is increasing 
evidence that preventative parenting interventions 
[…] have beneficial effects on children’s depression, 
anxiety, and internalizing problems.” Inviting the 
entire family into the therapy ensures that parental 
factors are also addressed. The observed increase in 
PAM reflects that parents had a higher perceived 
agency in relationship to the child’s psychiatric 
problems post-treatment. 
While collected data are not normally revealed to 
patients in trial settings unless they specifically ask for 
it, it is possible that sharing and discussing this 
information with patients and their relatives could 
further aid their understanding of their problems and 
enhance improvement, while honoring the principle 
of transparency; an ideal which narrative therapy 
holds dear. How could we honor the principle of 
transparency of the treatment, if we ”hide” the 
scores? This principle might sometimes be 
juxtaposing and at other times be opposing to the 
principle of thickening the narratives of preferred 
stories and not thickening the problematic narratives. 
We believed, that sharing the BYI and PAM might 
be thickening the problematic narratives. Our 
clinicians gave special attention to this, that sharing 
the psychometric measurement scores may affect 
patients’ view of their symptomatology or severity, 
and this may in turn alter their outcomes. So we 
decided to adhere to the general principle of not 
showing the results of the measurements to the 
clinicians or the families unless they asked for it after 
the treatment. In hindsight, we believe that this might 
have been wrong. We could have used the results 
from the pre-measurements as another kind of 
question, asking if the child’s answers made sense to 
the parents, asking the child to explain how they 
answered, and so on. This might have helped the 
families and clinicians further understand the 
problems they were dealing with.  
We want to share a story to underline this 
discussion for the readers to reflect on: Only a very 
few families were interested in seeing the results of 
their own measurements. But one family specifically 
asked for them, receiving the results after the last 
session. Their son had been referred because of an 
anxiety that tied him to his home. He was diagnosed 
with infantile autism, and the anxiety was explained 
as a result of insufficient attention to the autism from 
the school and the other contexts that the child was 
living in. This child had an almost normal pre-score 
for anxiety and a very high post-score for anxiety. 
Despite this, both he and the family agreed that they 
felt confident, that the anxiety no longer held him 
captive. The parents were at first astounded by this, 
as were we. We came to understand that the child’s 
autism had made it difficult for him to fully 
comprehend the questions concerning emotions 
before the therapy. But the therapy gave him a 
language for as well as ways of dealing with anxiety 
that enabled him to recognize, name and deal with 
anxiety from a powerful position. After therapy he 
was very aware of, and angry about, the tactics of 
anxiety and therefore rated them as very stressful in 
the questionnaire. These measurements are included 
in the statistics as this was an accidental finding. 
Nevertheless, this story adds to the calls for us to be 
transparent about measures and include the patients 
and families in all kinds of evaluations of our 
treatments.  
We find that our approaches make the results 
applicable for people working within our field, and 
we hope this will generate more interest in exploring 
how to use NFT as a treatment for children and 
adolescents with psychiatric problems. Since many 
children have complex psychiatric symptomatology 
and their problems have profound negative effect on 
the whole family, we find it imperative that we work 
diligently to develop treatments that seek to help not 
only across the diagnostic specters, but also seek to 
help the entire family. We find that this study shows 
that this endeavor is indeed possible.  
 
Limitations  
There are several limitations of the present study. 
First, due to its naturalistic design, the study did not 
have a placebo group or any randomization, so we 
cannot compare the outcomes to other treatment 
options. However, as our participants were referred 
to us only when treatment as usual (TAU) had failed 
to alleviate their symptoms, one could speculate that 
our outcomes were at least better than TAU. We 
would also have liked to do follow-up measurements.  
Second, our treatment manual states that treatment 
should continue until the families themselves feel 
that it is no longer necessary, rather than for a pre-
specified period of time. So, we did not explore the 
effect of NFT after a fixed dose of therapy. In a post-
hoc analysis, duration of treatment was significantly 
associated with decrease in BAI (p = 0.042), but not 
with any other BYI indices.  
Third, only 48 patients filled out the 
questionnaires, and complete datasets were available 
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for 42 (87.5%) patients at baseline and 36 (75%) at 
follow-up. However, we were still able to find 
significant changes in BYI outcomes. We believe the 
low number was due to a team culture that was not 
strongly focused on research, since data 
completeness did increase over time and this culture 
has since been addressed (28). 
 
Strengths 
Our relatively large sample, validated instruments 
and manualized therapy add further strength to the 
interpretation of our results, and the diversity of our 
patient group suggests that our protocol is applicable 
to real-life settings. We believe the biggest strength 
of this study is that it was carried out in a normal 
clinical setting, where patients come with very 
different symptomatology and family-context. This is 
very similar to other Danish CAMHS-settings, and as 
such would be easily transferable. Some will argue 
that our inclusion of patients with every kind of 
psychiatric problem is a limitation, and that a more 
homogenous sample might be more desirable. We 
argue that the diversity of problems reflects the way 
patients are generally referred to CAMHS. Therefore, 
this study has implications for clinicians in settings 
who meet with patients who have complex problems.  
In this respect, our manual differs to many other 
manuals. It does not address specific problems or 
diagnoses, aiming instead to give families a language 
and way of positioning themselves more powerfully 
in regard to their different problems. We consider 
that this approach is important, as many CAMHS 
work with children and adolescents who have 
complex symptomatology. We suggest that NFT 
might be an alternative choice of treatment for 
clinicians who find that treatment programs 
addressing “clear cut” problems have too narrow a 
focus.  
 
Future research 
Despite their limits, our results suggest that 
psychometric measurements can be used to evaluate 
the effect of NFT in clinical trials, making it possible 
to create an evidence base for the use of narrative 
therapy. The study adds to the growing number 
measuring the efficacy of narrative therapy. This 
research is still ongoing, and more studies are needed 
in this area to examine the qualitative and 
quantitative effects of narrative therapy.  
This study indicates that NFT has direct positive 
effects on psychopathological symptoms which are 
measurable by psychometric measurements and 
therefore it is possible to conduct more rigorous 
quantitative research on narrative therapy, even 
though narrative therapy is not directly tailored 
towards symptom reduction. This suggests it is 
possible to create more evidence for NFT using 
quantitative psychometric measurements, thus 
making NFT available to families seeking help in 
mental health institutions.  
Our study demonstrates how inspiring and 
important it is for clinicians to work in close 
collaboration with researchers, not only to produce 
evidence for NFT, but also to develop our treatments 
further. We hope this article will inspire more 
clinicians and researchers to collaborate, and that this 
might in turn make NFT available to an increasing 
proportion of children and adolescents with mental 
health problems. 
 
Summary 
This study investigated measurable and quantifiable 
effects of NFT on patients’ experience of specific 
psychiatric symptoms and parents’ sense of personal 
agency. The results showed statistical significant 
changes with a good effect size for children with 
severe symptomatology, across different diagnoses 
and co-morbidity, as well as positive changes for the 
parent’s sense of activation towards their child’s 
disease, indicating that NFT might be a possible 
choice of treatment for this population of patients 
and families. 
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